Induction Therapy in Pediatric Renal Transplant Recipients
Authors:
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 9 (5) , 323-341
Abstract
Induction therapy to prevent the acute rejection of mismatched allografts with the ultimate aim of prolonging the life of the allograft has been the cornerstone of immunosuppression since the...Keywords
This publication has 101 references indexed in Scilit:
- Genomic Profiling of Kidney Ischemia-Reperfusion Reveals Expression of Specific Alloimmunity-Associated Genes: Linking “Immune” and “Nonimmune” Injury EventsTransplantation Proceedings, 2006
- Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus MonotherapyAmerican Journal of Transplantation, 2006
- Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantationThe Journal of Pediatrics, 2006
- Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experiencePediatric Nephrology, 2004
- Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation1Transplantation, 2003
- Anti-Interleukin-2 Receptor Antibodies for the Prevention of Rejection in Pediatric Renal Transplant PatientsPediatric Drugs, 2003
- Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipientsPediatric Nephrology, 2002
- CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1999
- The pediatric nephrologist's dilemma: Growth after renal transplantation and its interaction with age as a possible immunologic variableThe Journal of Pediatrics, 1987
- TREATMENT OF CADAVERIC RENAL TRANSPLANT RECIPIENTS WITH TOTAL LYMPHOID IRRADIATION, ANTITHYMOCYTE GLOBULIN, AND LOW-DOSE PREDNISONEThe Lancet, 1985